16. Drugs of Abuse (Including Designer Drugs)

  1. Prof. Pavel Anzenbacher2,3 and
  2. Prof. Dr. Ulrich M. Zanger4
  1. Markus R. Meyer and
  2. Hans H. Maurer

Published Online: 4 JUN 2012

DOI: 10.1002/9783527630905.ch16

Metabolism of Drugs and Other Xenobiotics

Metabolism of Drugs and Other Xenobiotics

How to Cite

Meyer, M. R. and Maurer, H. H. (2012) Drugs of Abuse (Including Designer Drugs), in Metabolism of Drugs and Other Xenobiotics (eds P. Anzenbacher and U. M. Zanger), Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany. doi: 10.1002/9783527630905.ch16

Editor Information

  1. 2

    Palacky University at Olomouc, Dept. Pharmacology, Hnevotinska str. 3, 779 00 Olomouc, Czech Republic

  2. 3

    Palacky University at Olomouc, Faculty of Medicine and Dentistry, Department of Pharmacology and Inst. Mol. and Translational Medicine, Hnevotinska st. 3, Olomouc, 775 15, Czech Republic

  3. 4

    Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, University of Stuttgart (IKP), Auerbachstrasse 112, 70376 Stuttgart, Germany

Author Information

  1. Saarland University, Institute of Experimental and Clinical Pharmacology and Toxicology, Department of Experimental and Clinical Toxicology, 66421 Homburg (Saar), Germany

Publication History

  1. Published Online: 4 JUN 2012
  2. Published Print: 18 APR 2012

ISBN Information

Print ISBN: 9783527329038

Online ISBN: 9783527630905



  • drugs of abuse;
  • designer drugs;
  • amphetamine;
  • phenethylamine;
  • cathinone;
  • phencyclidine;
  • piperazine;
  • pyrrolidinophenones;
  • tryptamine


This chapter contains sections titled:

  • Introduction

  • Classic Drugs of Abuse

  • Designer Drugs of Abuse

  • References